Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
35020136
PubMed Central
PMC8753338
DOI
10.1007/s11764-021-01120-9
PII: 10.1007/s11764-021-01120-9
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, Childhood cancer, Long-term follow-up care, Paediatric oncology,
- MeSH
- COVID-19 * epidemiologie MeSH
- dítě MeSH
- lidé MeSH
- nádory * psychologie MeSH
- pandemie MeSH
- přežívající onkologičtí pacienti * psychologie MeSH
- přežívající MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: Long-term follow-up (LTFU) care is essential to optimise health outcomes in childhood cancer survivors (CCS). We aimed to assess the impact of the COVID-19 pandemic on LTFU services and providers. METHODS: A COVID-19 working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) distributed a questionnaire to LTFU service providers in 37 countries across Europe, Asia, North America, Central/South America, and Australia. The questionnaire assessed how care delivery methods changed during the pandemic and respondents' level of worry about the pandemic's impact on LTFU care delivery, their finances, their health, and that of their family and friends. RESULTS: Among 226 institutions, providers from 178 (79%) responded. Shortly after the initial outbreak, 42% of LTFU clinics closed. Restrictions during the pandemic resulted in fewer in-person consultations and an increased use of telemedicine, telephone, and email consultations. The use of a risk assessment to prioritise the method of LTFU consultation for individual CCS increased from 12 to 47%. While respondents anticipated in-person consultations to remain the primary method for LTFU service delivery, they expected significantly increased use of telemedicine and telephone consultations after the pandemic. On average, respondents reported highest levels of worry about psychosocial well-being of survivors. CONCLUSIONS: The pandemic necessitated changes in LTFU service delivery, including greater use of virtual LTFU care and risk-stratification to identify CCS that need in-person evaluations. IMPLICATIONS FOR CANCER SURVIVORS: Increased utilisation of virtual LTFU care and risk stratification is likely to persist post-pandemic.
City of Hope Comprehensive Cancer Center Duarte CA USA
Danish Cancer Society Research Center Copenhagen Denmark
Department of Epidemiology and Cancer Control St Jude Children's Research Hospital Memphis TN USA
Department of Oncology St Jude Children's Research Hospital Memphis TN USA
Department of Paediatrics Amsterdam UMC Amsterdam The Netherlands
Department of Paediatrics Skåne University Hospital Clinical Sciences Lund University Lund Sweden
Department of Pediatric Hematology and Oncology University Hospitals Leuven Leuven Belgium
Department of Pediatric Oncology Hospital Virgen del Rocío Sevilla Spain
Department of Pediatrics and Adolescent Medicine Kepler University Clinic Linz Austria
Department of Pediatrics Nippon Medical School Tokyo Japan
Division of Haematology Oncology The Hospital for Sick Children Toronto Canada
Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini Genova Italy
Faculty of Medicine University of Ljubljana Vrazov trg 2 Ljubljana Slovenia
Hospital Tunku Azizah Kuala Lumpur Malaysia
Leeds Institute of Medical Research University of Leeds Leeds LS2 9JT UK
Murdoch Childrens Research Institute Melbourne VIC Australia
Paediatric Integrated Cancer Centre Victoria Australia
Paediatric Oncology Tata Memorial Hospital Mumbai India
Princess Máxima Center for Pediatric Oncology Heidelberglaan 25 3584 CS Utrecht the Netherlands
Radiotherapy department Institute of Oncology Zaloska 2 1000 Ljubljana Slovenia
Republican Siauliai County Hospital Siauliai Lithuania
Royal Childrens Hospital Melbourne VIC Australia
St Anna Childrens Hospital Vienna Austria
Zobrazit více v PubMed
Turcotte LM, Liu Q, Yasui Y, et al. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort. J Clin Oncol. 2019;37(34):3310–3319. doi: 10.1200/JCO.19.00129. PubMed DOI PMC
Leerink JM, De Baat EC, Feijen EAM, et al. Cardiac disease in childhood cancer survivors: Risk prediction, prevention and surveillance: JACC CardioOncology State-of-the-Art Review. J Am Coll Cardiol CardioOnc. 2020;2(3):363–378. PubMed PMC
Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: a systematic review. Chest 2011. 2011;140(4):881–901. PubMed PMC
Friedman DN, Tonorezos ES, Cohen P. Diabetes and Metabolic Syndrome in Survivors of Childhood Cancer. Horm Res Paediatr. 2019;91(2):118–127. doi: 10.1159/000495698. PubMed DOI PMC
Perkins JL, Chen Y, Harris A, et al. Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2014;120(16):2514–2521. doi: 10.1002/cncr.28763. PubMed DOI PMC
Frederiksen LE, Mader L, Feychting M, et al. Surviving childhood cancer: a systematic review of studies on risk and determinants of adverse socioeconomic outcomes. Int J Cancer. 2019;144(8):1796–1823. doi: 10.1002/ijc.31789. PubMed DOI
Verbruggen LC, Wang Y, Armenian SH, et al. Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2020;67(12):e28702. doi: 10.1002/pbc.28702. PubMed DOI PMC
Forster VJ, Schulte F. Unique needs of childhood cancer survivors during the COVID-19 pandemic. Support Care Cancer. 2021;29(1):17–19. doi: 10.1007/s00520-020-05824-z. PubMed DOI PMC
Patt D, Gordan L, Diaz M, et al. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clin Cancer Inform. 2020;4:1059–1071. doi: 10.1200/CCI.20.00134. PubMed DOI PMC
Santoro GA, Grossi U, Murad-Regadas S, et al. DElayed COloRectal cancer care during COVID-19 Pandemic (DECOR-19): Global perspective from an international survey. Surgery. 2021;169(4):796–807. doi: 10.1016/j.surg.2020.11.008. PubMed DOI PMC
Mahl C, Melo LRS, Almeida MHA, et al. Delay in head and neck cancer care during the COVID-19 pandemic and its impact on health outcomes. Braz Oral Res. 2020;34:e126. doi: 10.1590/1807-3107bor-2020.vol34.0126. PubMed DOI
Papautsky EL, Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat. 2020;184(1):249–254. doi: 10.1007/s10549-020-05828-7. PubMed DOI PMC
Saab R, Obeid A, Gachi F, et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the Pediatric Oncology East and Mediterranean (POEM) group. Cancer. 2020;126(18):4235–4245. doi: 10.1002/cncr.33075. PubMed DOI PMC
Jammu AS, Chasen MR, Lofters AK, Bhargava R. Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020. Support Care Cancer. 2020;29(6):2841–2850. doi: 10.1007/s00520-020-05908-w. PubMed DOI PMC
Costello AG, Nugent BD, Conover N, Moore A, Dempsey K, Tersak JM. Shared Care of Childhood Cancer Survivors: A Telemedicine Feasibility Study. J Adolesc Young Adult Oncol. 2017;6(4):535–541. doi: 10.1089/jayao.2017.0013. PubMed DOI PMC
Kenney LB, Vrooman LM, Lind ED, et al. Virtual visits as long-term follow-up care for childhood cancer survivors: Patient and provider satisfaction during the COVID-19 pandemic. Pediatr Blood Cancer 2021; Published online February 8, 2021. doi: 10.1002/pbc.28927 PubMed PMC
Curtis ME, Clingan SE, Guo H, Zhu Y, Mooney LK, Hser YI. Disparities in digital access among American rural and urban households and implications for telemedicine-based services. J Rural Health 2021; Published online August 6, 2021. doi: 10.1111/jrh.12614. PubMed PMC
Friend AJ, Feltbower RG, Hughes EJ, Dye KP, Glaser AW. Mental health of long-term survivors of childhood and young adult cancer: A systematic review. Int J Cancer. 2018;143(6):1279–1286. doi: 10.1002/ijc.31337. PubMed DOI
Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2396–2404. doi: 10.1200/JCO.2008.21.1433. PubMed DOI PMC
Burghardt J, Klein E, Brähler E, et al. Prevalence of mental distress among adult survivors of childhood cancer in Germany-Compared to the general population. Cancer Med. 2019;8(4):1865–1874. doi: 10.1002/cam4.1936. PubMed DOI PMC
Michel G, Rebholz CE, Von der Weid NX, Bergstraesser E, Kuehni CE. Psychological distress in adult survivors of childhood cancer: the Swiss Childhood Cancer Survivor study. J Clin Oncol. 2010;28(10):1740–1748. doi: 10.1200/JCO.2009.23.4534. PubMed DOI
Fidler MM, Ziff EJ, Wang S, et al. Aspects of mental health dysfunction among survivors of childhood cancer. Br J Cancer. 2015;113(7):1121–1132. doi: 10.1038/bjc.2015.310. PubMed DOI PMC
Hudson MM, Oeffinger KC, Jones K, et al. Age-dependent changes in health status in the Childhood Cancer Survivor cohort. J Clin Oncol. 2015;33(5):479–491. doi: 10.1200/JCO.2014.57.4863. PubMed DOI PMC
Pahl DA, Wieder MS, Steinberg DM. Social isolation and connection in adolescents with cancer and survivors of childhood cancer: A systematic review. J Adolesc. 2021;87:15–27. doi: 10.1016/j.adolescence.2020.12.010. PubMed DOI
Hanghøj S, Pappot N, Hjerming M, Taarnhoj GA, Boisen KA, Pappot H. Experiences of Social Isolation During the COVID-19 Lockdown Among Adolescents and Young Adult Cancer Patients and Survivors. J Adolesc Young Adult Oncol. Published online February 18, 2021. doi: 10.1089/jayao.2020.0202 PubMed
European Centre for Disease Prevention and Control. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom. December 20, 2020.
Priesemann V, Balling R, Brinkmann MM, et al. An action plan for pan-European defence against new SARS-CoV-2 variants. Lancet. 2021;397(10273):469–470. doi: 10.1016/S0140-6736(21)00150-1. PubMed DOI PMC
Van Oosterhout C, Hall N, Ly H, Tyler KM. COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies. Virulence. 2021;12(1):507–508. doi: 10.1080/21505594.2021.1877066. PubMed DOI PMC